Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe changes are minor revision notes: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedFooter updates: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the Study Details page.SummaryDifference0.0%

- Check66 days agoChange DetectedThe site-wide government funding status notice has been removed, and this change does not affect the study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedNo additions or deletions were observed in the Study Details page between the screenshots. The page structure and key sections appear unchanged.SummaryDifference0.4%

- Check109 days agoChange DetectedMajor update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.SummaryDifference2%

Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.